loadpatents
name:-0.0083751678466797
name:-0.020841121673584
name:-0.0013730525970459
Ashton; Wallace T. Patent Filings

Ashton; Wallace T.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Ashton; Wallace T..The latest application filed is for "bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes".

Company Profile
0.19.4
  • Ashton; Wallace T. - Edison NJ
  • Ashton, Wallace T - Edison NJ
  • Ashton; Wallace T. - Clark NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
Grant 7,956,061 - Ashton , et al. June 7, 2
2011-06-07
Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
Grant 7,625,888 - Weber , et al. December 1, 2
2009-12-01
Bicyclic Pyrimidines as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
App 20090105210 - Ashton; Wallace T. ;   et al.
2009-04-23
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
Grant 7,388,019 - Ashton , et al. June 17, 2
2008-06-17
Fused Triazole Derivatives as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes
App 20070208010 - Weber; Ann E. ;   et al.
2007-09-06
3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
Grant 7,265,128 - Ashton , et al. September 4, 2
2007-09-04
Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
Grant 7,238,683 - Ashton , et al. July 3, 2
2007-07-03
Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
App 20060281727 - Ashton; Wallace T. ;   et al.
2006-12-14
Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
Grant 7,026,316 - Ashton , et al. April 11, 2
2006-04-11
Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
App 20040106656 - Ashton, Wallace T ;   et al.
2004-06-03
Amide derivatives as .beta. 3 agonists
Grant 6,291,491 - Weber , et al. September 18, 2
2001-09-18
Antagonists of gonadotropin releasing hormone
Grant 5,849,764 - Goulet , et al. December 15, 1
1998-12-15
Antagonists of gonadotropin releasing hormone
Grant 5,780,437 - Goulet , et al. July 14, 1
1998-07-14
Antagonists of gonadotropin releasing hormone
Grant 5,756,507 - Goulet , et al. May 26, 1
1998-05-26
Substituted triazolinones, triazolinethiones, and triazolinimines as angiotensin II antagonists
Grant 5,411,980 - Ashton , et al. May 2, 1
1995-05-02
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
Grant 5,312,820 - Ashton , et al. May 17, 1
1994-05-17
N,N-diacylpiperazines
Grant 5,292,726 - Ashton , et al. March 8, 1
1994-03-08
Substituted 1,2,4-triazoles bearing acidic functional groups as angiotensin II antagonists
Grant 5,281,614 - Ashton , et al. January 25, 1
1994-01-25
Substituted pyrazoles, compositions and use
Grant 5,262,412 - Ashton , et al. November 16, 1
1993-11-16
Antiherpetic agents
Grant 5,110,799 - Tolman , et al. May 5, 1
1992-05-05
Anti-viral guanine compounds
Grant 4,816,447 - Ashton , et al. March 28, 1
1989-03-28
9-(2-hydroxymethyl)cycloalkylmethyl) guanines
Grant 4,782,062 - Tolman , et al. November 1, 1
1988-11-01
Preparation of 5-deazariboflavins
Grant 4,277,603 - Tolman , et al. July 7, 1
1981-07-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed